Phenolphthalein laxatives ban proposed by FDA; Ex-Lax with senna to debut.
This article was originally published in The Tan Sheet
Executive Summary
NOVARTIS EX-LAX REFORMULATED WITH SENNA TO BE ON SHELVES IN 60 DAYS, the company said in a state-ment issued Aug. 29 responding to FDA's proposed rule banning the OTC sale of phenolphthalein. Phenolphthalein is the active ingredient in many products in Novartis' Ex-Lax line of laxatives.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: